Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women
PHASE4Not yet recruitingINTERVENTIONAL
Enrollment
150
Participants
Timeline
Start Date
July 31, 2022
Primary Completion Date
July 31, 2025
Study Completion Date
October 31, 2025
Conditions
Hepatitis B Virus - Chronic Active
Interventions
DRUG
Fumarate, Tenofovir Disoproxil
all participants receive the intervention
All Listed Sponsors
lead
ANRS, Emerging Infectious Diseases
OTHER_GOV
NCT05403047 - Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women | Biotech Hunter | Biotech Hunter